Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
Olson, Daniel J, Eroglu, Zeynep, Brockstein, Bruce, Poklepovic, Andrew S, Bajaj, Madhuri, Babu, Sunil, Hallmeyer, Sigrun, Velasco, Mario, Lutzky, Jose, Higgs, Emily, Bao, Riyue, Carll, Timothy C, Labadie, Brian, Krausz, Thomas, Zha, Yuanyuan, Karrison, Theodore, Sondak, Vernon K, Gajewski, Thomas F, Khushalani, Nikhil I, Luke, Jason J
Published in Journal of clinical oncology (20.08.2021)
Published in Journal of clinical oncology (20.08.2021)
Get full text
Journal Article
A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab
Olson, Daniel J, Rajagopal, Padma, Tjota, Melissa Y, Venkataraman, Girish, Luke, Jason J, Gajewski, Thomas F
Published in Journal for immunotherapy of cancer (01.03.2020)
Published in Journal for immunotherapy of cancer (01.03.2020)
Get full text
Journal Article
Checkpoint Blockade-Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines
Reschke, Robin, Shapiro, Jason W, Yu, Jovian, Rouhani, Sherin J, Olson, Daniel J, Zha, Yuanyuan, Gajewski, Thomas F
Published in Cancer immunology research (04.10.2022)
Published in Cancer immunology research (04.10.2022)
Get more information
Journal Article